OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Central Nervous System Lymphoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,355 reports · 47 co-occurring drugs

As of the last recalculation, Central Nervous System Lymphoma appears in 1,355 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 61.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Thiotepa3761.261.4
Vincristine Sulfate9654.154.3
Doxorubicin Hydrochloride8844.244.3
Doxorubicin19338.638.7
Cytarabine13437.938.0
Mycophenolate Mofetil25936.036.0
Mycophenolate Mofetil Hydrochloride25935.936.0
Rituximab36035.335.3
Temozolomide4231.631.6
Ifosfamide4029.429.5
Mycophenilic Acid3829.029.0
Cyclophosphamide Injection, Solution25927.527.6
Cyclophosphamide25927.527.6
Cyclophosphamide For Injection25927.527.6
Sirolimus2326.726.7
Alemtuzumab3226.026.0
Mycophenolic Acid3919.219.3
Etoposide8017.717.7
Anakinra1816.916.9
Methotrexate34116.316.3
Ganciclovir Sodium1116.116.1
Polatuzumab Vedotin1015.915.9
Ibrutinib7815.715.7
Ganciclovir1015.115.1
Methotrexate Sodium35815.015.0
Mesna Injection815.015.0
Prednisolone15514.814.8
Prednisolone Oral15514.814.8
Prednisolone Oral Solution15514.814.8
Tacrolimus Ointment 0.1%11014.714.7
Mesna814.714.7
Tacrolimus Extended-Release Capsules11014.614.7
Axicabtagene Ciloleucel914.114.1
Azathioprine7513.813.8
Tacrolimus12713.613.7
Lopinavir And Ritonavir1112.612.6
Filgrastim2811.711.7
Atovaquone611.511.5
Hydroxychloroquine5211.111.1
Efavirenz79.79.7
Obinutuzumab98.58.5
Tofacitinib Citrate78.28.2
Busulfan87.97.9
Bendamustine Hcl77.07.0
Baricitinib46.46.4
Bendamustine Hydrochloride45.15.1
Natalizumab544.74.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.